Conservest Capital Advisors Inc. Sells 468 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Conservest Capital Advisors Inc. decreased its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 8.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,029 shares of the company’s stock after selling 468 shares during the period. Conservest Capital Advisors […]

Leave a Reply

Your email address will not be published.

Previous post Aave Reaches Market Capitalization of $1.21 Billion (AAVE)
Next post 385 Shares in SPDR S&P MidCap 400 ETF Trust (NYSEARCA:MDY) Purchased by Summit Financial Wealth Advisors LLC